News

FDA Accepts Pfizer (PFE) Vepdegestrant NDA for Breast Cancer, Fast Track Designation Awarded
Pfizer (PFE) recently announced that the U.S. Food and Drug Administration accepted the New Drug Application for ...
24/7 Wall St. on MSN8h
5 Strong Buy Dividend Stocks for Huge Passive Income
A value stock is generally a company that trades at a price lower than its fundamental value or what its performance suggests ...
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
About Vepdegestrant Vepdegestrant is an investigational, orally bioavailable PROteolysis TArgeting Chimera (PROTAC) estrogen receptor degrader. Vepdegestrant is being developed as a potential ...